PROUS INSTITUTE PRESENTS THE 12TH EDITION OF THE PROUS INSTITUTE - OVERTON & MEYER AWARD FOR NEW TECHNOLOGIES IN DRUG DISCOVERY TO PROF. TIMOTHY NOËL (UNIVERSITY OF AMSTERDAM, THE NETHERLANDS)
Prous Institute for Biomedical Research is to present the 2026 Prous Institute – Overton & Meyer Award to Professor Timothy Noël, at the International Symposium on Medicinal Chemistry 2026 organized by the European Federation of Medicinal Chemistry and Chemical Biology (EFMC).
The award, conferred every two years since 2004 and now in its twelfth edition, recognizes outstanding contributions to the development of new technologies in the field of medicinal chemistry and acknowledges the awardee’s contribution to the discovery and development of innovative technologies that advance the field.
Prof Noël is is Full Professor and Chair of Flow Chemistry at the University of Amsterdam Van’t Hoff Institute for Molecular Sciences (HIMS). Prof Noël founded and directs the Noël Research Group focusing on exciting new approaches to enable challenging reactions, and a recognized leadership position in the field of flow chemistry.
Prof Noël is the (co)author of more than 250 peer-reviewed publications and his research has been rewarded by several awards, including the DECHEMA award (2017), the Hoogewerff Youth Prize (2019), the IUPAC-ThalesNano Flow Chemistry Award (2020), the KNCV Gold Medal (2021), ERC Consolidator Grant (2022), the ACS Sustainable Chemistry & Engineering Lectureship Award (2022) and the ChemSocRev Pioneering Investigator Lectureship (2023). He was named Fellow of the Royal Society of Chemistry in 2024 and is also the editor in chief of Journal of Flow Chemistry and the current President of the Flow Chemistry Society.
The award will be presented during the International Symposium on Medicinal Chemistry (EFMC-ISMC 2026), to be held in Basel, Switzerland, on September 6, 2026. The Award plenary Lecture is scheduled for Tuesday, September 8, 2026.
About the Prous Institute for Biomedical Research
Prous Institute for Biomedical Research, created as a spin-off of Prous Science (acquired by Thomson Reuters, now Clarivate Analytics, in 2007) is committed to supporting the discovery of novel therapeutic and diagnostic approaches.
Originally founded by Dr. J.R. Prous, Prous Institute has evolved to expand its mission beyond its own developments by partnering and investing in transformative science initiatives.
By leveraging more than 60 years’ experience in the life sciences, we offer the resources and capabilities needed by researchers to move their research closer to the patient bedside.
About the European Federation of Medicinal Chemistry (EFMC)
The EFMC is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.